group of bacteria with high genetic similarities and were designated as Nocardia asteroides complex [6, 1] . Wallace and colleagues described six drug susceptibility pattern types among 78 clinical isolates previously identified as "Nocardia asteroides." Their work was the most significant study of antimicrobial susceptibilities of Nocardia asteroides that revealed the variability of drug susceptibility patterns among the isolates and the first to show a grouping of specific susceptibility patterns. Later in the 1990s, with the development of molecular techniques, molecular taxonomy studies revealed that Nocardia abscessus belonged to the first drug susceptibility pattern. Similarly, Nocardia brevicatena-paucivorans complex was categorized in the second drug susceptibility pattern, Nocardia nova complex (Nocardia nova, Nocardia veterana, Nocardia africana, and Nocardia kruczakiae) in the third drug susceptibility pattern, Nocardia transvalensis complex (N. transvalensis sensu stricto, Nocardia wallacei, and Nocardia blacklockiae) in the fourth drug susceptibility pattern, and Nocardia farcinica and Nocardia cyriacigeorgica in the fifth and sixth patterns of drug susceptibility, respectively [1] . According to the difference in the susceptibility pattern of each member of the Nocardia asteroides complex, it can be concluded that prescription of effective antibiotics should be after the accurate identification of the causative Nocardia species. Also, clinical studies showed that some Nocardia species such as Nocardia otitidiscaviarum and Nocardia beijingensis could cause systematic infections, while other species like Nocardia brasiliensis cause limited local infections [1, [6] [7] . Trimethoprim-sulfamethoxazole, amikacin, and imipenem are usually the first drug choices for nocardiosis [7] . However, the rate of fatality among patients with pulmonary and brain abscess who consumed trimethoprim-sulfamethoxazole ranged from 20 to 50% [8] .
